Gastrointestinal prokinetic therapy: Acetylcholinesterase inhibitors

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 19, Issue 5, 1997, Pages 615-620

  Hall, Jean A ^a,c   Washabau, Robert J ^b,c  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c AMER COLL OF VET INT MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS; FELIS CATUS;

EID: 0141877420     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. 2-receptor antagonists, ranitidine, cimetidine, and metiamide. Gut 21:408-412, 1980.
2. 2-receptor antagonist. Gut 21:187-191, 1980.
3. 2-receptor antagonists, ranitidine and cimetidine, in the anesthetized dog. Br J Pharmacol 72:55-60, 1981.
4. Brogden RN, Carmine AA, Heel RC, et al: Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24:267-303, 1982.
5. 2-receptor antagonist. Clin Pharmacol 1:499-509, 1982.
6. Roberts CJ: Clinical pharmacokinetics of ranitidine. Clin Pharmacokinet 9:211-221, 1984.
7. 2-receptor antagonists on gastrointestinal motility. Agents Actions 13:157-162, 1983.
8. Fioramonti J, Soldani G, Honde C, et al: Effects of ranitidine and oxmetidine on gastrointestinal motility in conscious dog. Agents Actions 15:260-263, 1984.
9. 2 receptors. Pharm Res Commun 17:241-254, 1985.
10. 2-receptor antagonists in the dog: Their possible role in gastric motor activity. J Gastrointest Motil 2(4):273-280, 1990.
11. Kishibayashi N, Tomaru A, Ichikawa S, et al: Enhancement by KW-5092, a novel gastroprokinetic agent, of the gastrointestinal motor activity in dogs. Jpn J Pharmacol 65: 131-142, 1994.
12. Bell JA, Dallas FA, Jenner WN, Martin LE: The metabolism of ranitidine in animals and man. Biochem Soc Trans 8:93, 1980.
13. Papich MG: Medical therapy for gastrointestinal ulcers, in Kirk RW (ed): Current Veterinary Therapy. X. Small Animal Practice. Philadelphia, WB Saunders Co, 1989, pp 911-918.
14. Halpern NA, Colucci RD, Turk J, et al: Segmental intestinal absorption of ranitidine: Investigative and therapeutic implications. Am J Gastroenterol 85(5):539-543, 1990.
15. Willard M: General therapeutic principles, in Nelson RW, Couto CG (eds): Essentials of Small Animal Internal Medicine. St. Louis, Mosby-Year Book, 1992, p 311.
16. Francavilla A, Makowka L, Polimeno L, et al: A dog model for acetaminophen-induced fulminant hepatic failure. Gastroenterology 96:470-478, 1989.
17. Fioramonti J, Bueno L: Gastrointestinal myoelectric activity disturbances in gastric ulcer disease in rats and dogs. Dig Dis Sci 25:575-580, 1980.
18. Yoshida N, Karasawa T, Kadokawa T: Effect of metoclopramide and ranitidine on acetylcholine release from isolated rat stomach. Arch Int Pharmacodyn 295:245-256, 1988.
19. Vashi VI, Meyer MC: Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs. J Pharm Sci 77(9):760-764, 1988.
20. Klein J, Bentur Y, Cheung D, et al: Renal handling of cisplatin: Interactions with organic anions and cations in the dog. Clin Invest Med 14(5):388-394, 1991.
21. 2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs. J. Pharmacol Exp Therap 239:406-410, 1986.
22. Lin T-M, Evans DC, Warrick MW, et al: Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions. J Pharmacol Exp Therap 239:400-405, 1986.
23. 2-receptor antagonist, on gastric acid secretion in Heidenhain pouch dogs. Therap Res 10(1):337-342, 1989.
24. 2-receptor antagonist, and its possible mechanism of action in dogs and rats. J Pharmacol Exp Therap 264(1):152-157, 1993.
25. 2-antagonists modify gastric emptying in the rat. Br J Pharmacol 77: 443-448, 1982.
26. Sano H, Sato H, Furuta S, et al: Pharmacokinetics of nizatidine in dogs and rats. Xenobiotica 21(10):1257-1264, 1991.
27. Morton DM: Pharmacology and toxicology of nizatidine. Scand J Gastroenterol 22(Suppl 136):1-8, 1987.
28. Bemis K, Bendele A, Clemens J: General pharmacology of nizatidine in animals. Arzneimittelforschung 39:240-250, 1989.
29. Parkman HP, Pagano AP, Ryan JP: Ranitidine and nizatidine stimulate antral smooth muscle contractility via an excitatory cholinergic mechanism. Gastroenterology 106:A553, 1994.
30. 14C-nizatidine in the gastric wall of rats. Arzneimittelforschung 41(9): 958-961, 1991.
31. 2-receptor antagonist: Acute, subchronic, and chronic toxicity evaluations. Fundam Appl Toxicol 13(4):778-792, 1989.